August 28, 2025

Does Changing Biologics Clear Skin Faster?

The psoriasis treatment ladder may not apply to interclass biologic switching.

Conexiant

August 28, 2025

Girl With Waterdrop-Like Papules: What’s Your Diagnosis?

A teenager with atopic dermatitis presented with several painless, flesh-colored papules limited to the trunk. Dermoscopy and biopsy show selective loss of elastic fibers after prior molluscum contagiosum. What’s your diagnosis?

Conexiant

August 25, 2025

Did Politics Delay CDC Measles Response?

Emails and interviews show CDC scientists were sidelined during the West Texas surge, leaving local officials without guidance as cases spread across the US and into Mexico.

KFF Health News

August 22, 2025

Nemolizumab Study Tracks 68 Weeks of Relief

A long-term clinical study finds that the biologic therapy nemolizumab, when used with topical corticosteroids, continues to improve itch, sleep, and skin symptoms in prurigo nodularis patients over 68 weeks.

Conexiant

August 14, 2025

Dalbavancin Holds Its Own Against S. aureus Bacteremia, Study

"All treatments currently approved with an indication for bacteremia require prolonged intravenous access."

Conexiant

August 06, 2025

Bimekizumab Sustains Psoriasis Response for 3 Years

A 3-year analysis of a phase IIIb trial found that bimekizumab, a dual interleukin-17A and interleukin-17F inhibitor, maintained high rates of skin clearance and demonstrated a consistent safety profile in patients with moderate-to-severe plaque psoriasis, including those who switched from secukinumab, an interleukin-17A inhibitor.

Conexiant

August 04, 2025

Beta-HPV–Driven SCC Resolved After TCR Signaling Correction

Case study shows cutaneous squamous cell carcinoma linked to beta-human papillomavirus cleared following T-cell immune restoration.

Conexiant

April 29, 2024

First Death From Alaskapox Reported

Alaska health officials warned of the risk of Alaskapox in the wake of the first death from the disease in January 2024.

Conexiant

June 12, 2024

FAc Implant Shows Sustained Improvement in Uveitis

Long-term study highlights effectiveness of fluocinolone acetonide implant in managing non-infectious posterior uveitis, maintaining stable intraocular pressure.

Conexiant